Skip to main content
. 2020 Jun 26;20:1009. doi: 10.1186/s12889-020-09136-z

Table 3.

Direct medical expenses and medical costs, by hospitalization

Variables Hospitalisation Non-hospitalisation P-value*
RS
 Direct medical expenses (US$)
  Mean (SD.) 3241.7 (3240.4) 1065.0 (1125.8)
  Median(p25,p75) 2437.0 (1670.43407.4) 859.3 (563.0,1255.6) < 0.001
 Medical costs (US$)
  Mean (SD.) 2094.7 (2623.8) 703.4 (994.9)
  Median(p25,p75) 1422.2 (825.92303.7) 518.5 (296.3959.3) < 0.001
RMR
 Direct medical expenses (US$)
  Mean (SD.) 11,739.3 (8984.6) 2268.1 (2949.9)
  Median(p25,p75) 11,133.3 (4996.316174.1) 1540.7 (488.92440.7) < 0.001
 Medical costs (US$)
  Mean (SD.) 8460.0 (9204.2) 983.7 (971.3)
  Median(p25,p75) 4311.1 (2525.912111.1) 763.0 (92.61825.9) < 0.001
MDR
 Direct medical expenses (US$)
  Mean (SD.) 12,559.6 (8252.9) 1363.0 (1033.6)
  Median(p25,p75) 11,348.1 (7103.716874.1) 1688.9 (511.11888.9) < 0.001
 Medical costs (US$)
  Mean (SD.) 9666.3 (8691.5) 855.6 (1033.3)
  Median(p25,p75) 7948.1 (3455.613151.9) 348.1 (0.0,1533.3) < 0.001

Note: US$: United States dollar

A currency exchange rate of Chinese RMB 675 Yuan to US$ 100 Yuan (at the end of 2017)

RS rifampicin-susceptible

RMR rifampicin-monoresistant

MDR multidrug-resistant

*Mann-Whitney test